0001127602-23-003927.txt : 20230208
0001127602-23-003927.hdr.sgml : 20230208
20230208104518
ACCESSION NUMBER: 0001127602-23-003927
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230201
FILED AS OF DATE: 20230208
DATE AS OF CHANGE: 20230208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gajewski Kristen
CENTRAL INDEX KEY: 0001964933
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16091
FILM NUMBER: 23597572
MAIL ADDRESS:
STREET 1: 33587 WALKER ROAD
CITY: AVON LAKE
STATE: OH
ZIP: 44012
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVIENT CORP
CENTRAL INDEX KEY: 0001122976
STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
IRS NUMBER: 341730488
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33587 WALKER ROAD
CITY: AVON LAKE
STATE: OH
ZIP: 44012
BUSINESS PHONE: 440-930-1000
MAIL ADDRESS:
STREET 1: 33587 WALKER ROAD
CITY: AVON LAKE
STATE: OH
ZIP: 44012
FORMER COMPANY:
FORMER CONFORMED NAME: POLYONE CORP
DATE OF NAME CHANGE: 20000830
3
1
form3.xml
PRIMARY DOCUMENT
X0206
3
2023-02-01
0
0001122976
AVIENT CORP
AVNT
0001964933
Gajewski Kristen
AVIENT CENTER
AVON LAKE
OH
44012
1
SVP & CHRO
Common Stock
929
D
Common Stock
840.407
I
Savings Plan Trust
Common Stock
95.234
I
Supplemental Plan
Restricted Stock Units
2023-02-10
Common Stock
769
D
Restricted Stock Units
2024-02-08
Common Stock
670
D
Restricted Stock Units
2025-02-14
Common Stock
668
D
Stock Appreciation Rights
41.89
2028-02-14
Common Stock
1150
D
Stock Appreciation Rights
31.54
2029-02-11
Common Stock
700
D
Stock Appreciation Rights
31.48
2030-02-10
Common Stock
1466
D
Stock Appreciation Rights
42.27
2031-02-08
Common Stock
2570
D
Stock Appreciation Rights
52.64
2032-02-11
Common Stock
2300
D
The information in this report is based on a plan statement as of February 1, 2023.
The restricted stock units vest 3 years from the date of grant on February 10, 2023.
The restricted stock units include all dividend equivalents acquired since the date of grant. Dividend equivalents are subject to the same restrictions as the underlying grant of restricted stock units.
The restricted stock units vest 3 years from the date of grant on February 8, 2024.
The restricted stock units vest 3 years from the date of grant on February 14, 2025.
SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years.
SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.
SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years.
SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $42.27 per share and no more than one-third of the grant can vest per year during the first three years.
SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.
/s/ Lisa K. Kunkle, Power of Attorney For: Kristen Gajewski
2023-02-08
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY
Power of Attorney
Know all by these presents that the undersigned hereby constitutes and
appoints each of Robert M. Patterson, Jamie A. Beggs and Lisa K.
Kunkle, signing singly, the undersigned's true and lawful attorney-in-fact
to:
1. Prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission (the
"SEC") a Form ID, including amendments thereto, and any other documents
necessary or appropriate to obtain codes and passwords enabling the
undersigned to make electronic filings with the SEC of reports required
by Section 16(a) of the Securities Exchange Act of 1934 or any rule or
regulation of the SEC; and
2. Execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of PolyOne
Corporation (the "Corporation"), Forms 3, 4, and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934 and the
rules thereunder; and
3. Do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Form 3, 4, or 5 and timely file such form with
the SEC and any stock exchange or similar authority; and
4. Take any other action of any type whatsoever in connection with
the foregoing which, in the opinion of such attorney-in-fact, may
be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of
the undersigned, are not assuming, nor is the Corporation assuming, any of
the undersigned's responsibility to comply with Section 16 of the Securities
Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to
the undersigned's holdings of and transactions in securities issued by the
Corporation, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 18th day of January 2023.
/s/ Kristen Gajewski
____________________________
Kristen Gajewski